Abstract:Toll-like receptors (TLRs) are primary sensors to detect conserved patterns on microorganisms, thus acting as the important components of innate immunity against invading pathogens. Protein tyrosine phosphatase-1B (PTP1B) has been shown to be a critical negative regulator of insulin pathway and other cellular signaling, however, whether and how PTP1B regulates TLR-triggered innate response remain to be investigated. We report here that PTP1B can markedly decrease TNF-α, IL-6 and IFN-β production by macrophages stimulated with LPS, CpG ODN, or Poly I:C. Accordingly, knockdown of endogenous PTP1B expression increases production of TNF-α, IL-6 and IFN-β in macrophages stimulated with TLR ligands. Phosphatase activity-disrupted mutant PTP1B cannot inhibit TLR-triggered production of proinflammatory cytokines and IFN-β, indicating PTP1B exerts its suppressive activity in phosphatase-dependent manner. PTP1B inhibits TLR ligands-induced activation of MAPKs, NF-κB, and IRF3, furthermore, co-transfection of PTP1B inhibits both MyD88- and TRIF-induced transcription of TNF-α and IFN-β reporter genes in a dose-dependent manner. In addition, PTP1B inhibits LPS-induced Tyk2 and STAT1 activation. Therefore, we demonstrate that phosphatase PTP1B is a physiological negative regulator of TLR signaling via suppression of both MyD88- and TRIF-dependent production of proinflammatory cytokine and IFN-β in macrophages. Our results provide new mechanistic explanation for negative regulation TLR response and suggest PTP1B as a potential target for the intervention of the inflammatory diseases.

The P38‐interacting Protein P38ip Suppresses TCR and LPS Signaling by Targeting TAK1

Β-Arrestin 2 Negatively Regulates Toll-like Receptor 4 (Tlr4)-Triggered Inflammatory Signaling Via Targeting P38 MAPK and Interleukin 10.

USP19 Inhibits TNF-α– and IL-1β–Triggered NF-κB Activation by Deubiquitinating TAK1

p38α deficiency ameliorates psoriasis development by downregulating STAT3-mediated keratinocyte proliferation and cytokine production

E3 ubiquitin ligase tripartite motif 38 negatively regulates TLR-mediated immune responses by proteasomal degradation of TNF receptor-associated factor 6 in macrophages.

P38α Signaling Programs Dendritic Cells to Drive TH17 Cell Differentiation and Function (48.14)

Gene Suppression by Tristetraprolin and Release by the P38 Pathway

IL-1β/p38 signaling controls IL-17 production by T regulatory cells (139.3)

Tumor Necrosis Factor‑α‑induced Protein‑8 Like 2 Regulates Lipopolysaccharide‑induced Rat Rheumatoid Arthritis Immune Responses and is Associated with Rac Activation and Interferon Regulatory Factor 3 Phosphorylation.

TRIM26 Positively Regulates the Inflammatory Immune Response Through K11-linked Ubiquitination of TAB1

P38 MAPK is Critical for Nuclear Translocation of IRF-7 During CpG-induced Type I IFN Expression in Human Plasmacytoid Dendritic Cells

Signaling Via the Kinase P38α Programs Dendritic Cells to Drive TH17 Differentiation and Autoimmune Inflammation.

Raf Kinase Inhibitor Protein Preferentially Promotes Tlr3-Triggered Signaling and Inflammation

E3 Ubiquitin Ligase Nedd4 Inhibits AP-1 Activity and TNF-α Production Through Targeting P38α for Polyubiquitination and Subsequent Degradation

USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex.

Feedback Control of MKP-1 Expression by P38

USP38 Inhibits Type I Interferon Signaling by Editing TBK1 Ubiquitination Through NLRP4 Signalosome.

Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.

P38α Has an Important Role in Antigen Cross-Presentation by Dendritic Cells.

Control of T Cell Fates and Immune Tolerance by P38α Signaling in Mucosal Dendritic Cells (P3177)

TAK1 Negatively Regulates NF-κB and P38 MAP Kinase Activation in Gr-1+CD11b+ Neutrophils.